CornerCap Investment Counsel »

Sage Therapeutics shares owned by CornerCap Investment Counsel

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by CornerCap Investment Counsel from 13F filings

Historical chart of CornerCap Investment Counsel investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by CornerCap Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by CornerCap Investment Counsel

Quarter filed Position value Share count Share price at filing
2023-12-31 $239k 11k 21.67
2023-09-30 $228k 11k 20.58
2023-03-31 $209k 5.0k 41.96

More positions owned by CornerCap Investment Counsel

Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Cisco Systems (CSCO)
Apple (AAPL)
CSX Corporation (CSX)
Microsoft Corporation (MSFT)
Emerson Electric (EMR)
Merck & Co (MRK)
Booking Holdings (BKNG)
Fnf (FNF)
Bristol Myers Squibb (BMY)
Intel Corporation (INTC)

View all positions for CornerCap Investment Counsel

Top funds holding Sage Therapeutics

Wellington Management Company
Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Deutsche Bank Aktiengesellschaft
Palo Alto Investors
Dimensional Fund Advisors
Samlyn Capital
Jacobs Levy Equity Management
Citadel Advisors
T. Rowe Price Associates
Goldman Sachs Group
Cowen And Company
Fisher Investments
Charles Schwab Investment Management

View all funds holding Sage Therapeutics